Oncothyreon Inc (ONTY.OQ)
|Market Cap (Mil.):||$253.00|
|Shares Outstanding (Mil.):||69.31|
Sept 25 - U.S. stocks dipped in choppy trading on Wednesday, with the S&P 500 eyeing a fifth day of losses, as a lack of progress in budget negotiations in Washington puzzled investors. The Dow Jones industrial average fell 0.04 percent, to 15,329.13, the S&P 500 lost 0.07 percent, to 1,696.25 and the Nasdaq Composite dropped 0.05 percent, to 3,766.296.
Sept 25 - U.S. stocks edged up at the open on Wednesday, following four days of losses on the S&P 500 and Dow, even as a lack of progress in budget negotiations in Washington left investors puzzled. The Dow Jones industrial average was up 0.08 percent, the S&P 500 was up 0.05 percent and the Nasdaq Composite was up 0.12 percent.
Sept 25 - U.S. stock index futures were little changed on Wednesday, following four days of losses on the S&P 500 and Dow, as investors grew increasingly concerned about budget and debt negotiations in Washington. S&P 500 futures fell 3 points, Dow Jones industrial average futures rose 3 points, and Nasdaq 100 futures lost 6 points.
Sept 25 - U.S. stock index futures were little changed on Wednesday. S&P 500 futures fell 0.18 percent, Dow Jones industrial average futures fell 0.02 percent and Nasdaq 100 futures fell 0.18 percent.
|CHUGAI PHARMACEUTICAL CO., LTD. (4519.T)||¥2,579||+14.00|
|Novartis AG (NOVN.VX)||CHF72.90||+0.30|
|Roche Holding Ltd. (ROG.VX)||CHF260.30||-0.20|
|Bayer AG (BAYGn.DE)||€95.63||-0.81|
|Bayer AG (BAYE.F)||--||--|
|Sanofi SA (SASY.PA)||€74.04||-1.05|
|GlaxoSmithKline plc (GSK.L)||1,674.00p||+1.50|
|Eli Lilly & Co. (LLY.N)||$58.37||-0.53|
|Transgene SA (TRNG.PA)||€12.22||-0.13|
Earnings vs. Estimates
Analyst Research Reports
Provider: S&P Capital IQ Quantitative Report
Provider: Pechala's Reports
Oncothyreon Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Ford Investor Services, Inc.
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ONCOTHYREON INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.
Provider: Jefferson Research